Upload Image (Max 20MB per Image)
Discovery Laboratories (DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has initiated the US commercial launch of Surfaxin (lucinactant) Intratracheal Suspension for the ...
Tags: DSCO, Surfaxin, RDS, Deerfield